Mediplantex National Pharmaceutical JSC

41
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MED5
VND
25,200.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Mediplantex National Pharmaceutical JSC Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
19,337.00
14,923.00
8,236.00
5,369.00
30,984.00
45,037.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
10,001.00
-42,289.00
-20,937.00
53,208.00
61,444.00
71,962.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
35,640.00
-30,093.00
-4,265.00
65,477.00
92,729.00
117,151.00
Cash Flow from Investing Activities
8,915.00
25,239.00
-127,268.00
-47,354.00
-58,219.00
-42,255.00
Cash Flow from Financing Activities
-45,478.00
-32,798.00
166,456.00
-25,220.00
-24,302.00
-38,270.00
Net Cash Inflow / Outflow
-922.00
-37,649.00
34,982.00
-6,982.00
10,219.00
36,636.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
2.00
60.00
115.00
10.00
10.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Mediplantex National Pharmaceutical JSC
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Profit Before Tax
19337.915777
137093.249919
-1,17,756.00
-85.89%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
10001.348251
-80571.508861
90,572.00
112.41%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
35640.856639
42951.982624
-7,311.00
-17.02%
Cash Flow from Investing Activities
8915.15895
-33713.628676
42,628.00
126.44%
Cash Flow from Financing Activities
-45478.485152
-95943.306
50,465.00
52.60%
Net Cash Inflow / Outflow
-922.469563
-86679.648802
85,757.00
98.94%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
25.30325
-25.00
-100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 218.43% vs -605.47% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
35,640.86
-30,093.61
218.43%